Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DelMar Pharmaceuticals Inc (OTCQX US:DMPID)

6.24
Delayed Data
As of 3:51pm ET
 -0.05 / -0.79%
Today’s Change
1.72
Today|||52-Week Range
6.31
+65.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization0.00--2.6K3.9K
 
 
 
 
Operating ExpensesGross Income0.000.00-2.6K-3.9K
 
 
 
General Expenses1.2M1.1M1.7M1.4M
 
 
 
 
 
Research And Development630.1K603.8K789.2K790.3K
 
 
 
 
 
Total Operating Expenses1.2M1.1M1.7M1.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.2M-1.1M-1.7M-1.4M
 
 
 
 
 
Extraordinary Credit904.4K0.000.00269.6K
 
 
 
Extraordinary Charge0.00-561.0K-922.6K--
 
 
 
Other Expenses-6.9K17.5K-44.3K10.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-299.5K-1.6M-2.6M-1.1M
 
 
 
 
 
Net Income-299.5K-1.6M-2.6M-1.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.9M10.6M11.0M11.1M
 
 
 
 
 
Shares To Calculate EPS Diluted9.9M10.6M11.0M11.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03-$0.16-$0.24-$0.12
 
 
 
 
 
EPS Diluted-$0.03-$0.16-$0.24-$0.12